ArticlePloS one2015

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.

Ryoichi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.